http://sciencecommons.org/weblog/archives/2006/11/02/bioitworld-degraaf-interview/ Fri, 11 Jun 2010 09:41:04 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://sciencecommons.org/weblog/archives/2006/11/02/bioitworld-degraaf-interview/comment-page-1/#comment-357 Andre Tue, 07 Nov 2006 07:40:23 +0000 http://sciencecommons.org/weblog/archives/2006/11/02/bioitworld-degraaf-interview/#comment-357 Knowledge Management is a big topic these days. There is a lot of knowledge unused in many firms - it is important to use this knowledge in the future. Science Commons is a way to deal with that problem. Knowledge Management is a big topic these days. There is a lot of knowledge unused in many firms – it is important to use this knowledge in the future. Science Commons is a way to deal with that problem.

]]> http://sciencecommons.org/weblog/archives/2006/11/02/bioitworld-degraaf-interview/comment-page-1/#comment-260 Biological content: Access and monetization at business|bytes|genes|molecules Thu, 02 Nov 2006 23:59:48 +0000 http://sciencecommons.org/weblog/archives/2006/11/02/bioitworld-degraaf-interview/#comment-260 [...] Update:I had totally forgotten about science commons, but thanks to a new post in my feed reader, I would like to point people there. The latest post is about an interview with David de Graaf, director of systems biology at Pfizer. I would like to point out that Teranode (where Eric works) is involved with science commons as well. [...] [...] Update:I had totally forgotten about science commons, but thanks to a new post in my feed reader, I would like to point people there. The latest post is about an interview with David de Graaf, director of systems biology at Pfizer. I would like to point out that Teranode (where Eric works) is involved with science commons as well. [...]

]]>